EGFR and neoplasm: Only one study (Huang et al., 2018) found that eNOS 894 G/T variants were significantly associated with EGFR mutation types of lung adenocarcinoma, specifically exon 19 in-frame deletion and that this could be used to predict tumor invasiveness and response to therapy.